328
21
1
737
8
Cat. No. | Product Name | ||
---|---|---|---|
L1710 | 抗COVID-19化合物库 | 1133 compounds | |
1133 种对SARS-CoV-2有抑制作用或潜在抑制作用的化合物集合,可用于高通量和高内涵筛选; |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T79455 |
SARS-CoV-2 Mpro-IN-9
SARS-CoV-2 Mpro IN 9,SARS-CoV-2 Mpro-IN 9 |
SARS-CoV | Microbiology/Virology |
SARS-CoV-2 Mpro-IN-9 (SARS-CoV-2 Mpro IN 9) 是一种高效的 SARS-CoV-2 Mpro 抑制剂,IC50 值为 80 nM。SARS-CoV-2 Mpro-IN-9 具有抗病毒活性,抑制3C样半胱氨酸蛋白酶,可用于研究病毒感染。 | |||
T77510 |
SARS-CoV-2-IN-46
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-46 是一种 SARS-CoV-2 抑制剂。 | |||
T77516 |
SARS-CoV-2-IN-39
|
Antiviral; SARS-CoV | Immunology/Inflammation; Microbiology/Virology |
SARS-CoV-2-IN-39是一种 SARS-CoV-2 抑制剂,EC50 为 1 μM。 SARS-CoV-2-IN-39 具有抗病毒活性,通过抑制 SKP2 蛋白并稳定 BECN1 来抑制 SARS-CoV-2。 | |||
T77652 |
SARS-CoV-2 3CLpro-IN-20
|
Antiviral; SARS-CoV | Immunology/Inflammation; Microbiology/Virology |
SARS-CoV-2 3CLpro-IN-20 是一种共价的 SARS-CoV-2 3CLpro 抑制剂(IC50s: 0.43 μM,)。SARS-CoV-2 3CLpro-IN-20 具有潜在的抗病毒活性。 | |||
T60538 |
SARS-CoV-2-IN-14
3',5-Dichlorosalicylanilide |
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-14 是一种有效的、可口服的 SARS-CoV-2 抑制剂(IC50 :0.39 μM),是一种氯硝柳胺类似物。SARS-CoV-2-IN-14在人血浆和肝 S9 酶测定中比氯硝柳胺稳定性更强。SARS-CoV-2-IN-14以口服的方式给药可以提高其生物利用度和半衰期。 | |||
T9458 |
PF-00835231
|
SARS-CoV | Microbiology/Virology |
PF-00835231 是一种 CoV-2 半胱氨酸 3C 样蛋白酶抑制剂,对 SARS CoV-2 和 SARS CoV-1 3CLpro 的 IC50 分别为 0.27 nM 和 4 nM。它用于抗 SARS-CoV-2/COVID-19 的研究。 | |||
T12838 |
SARS-CoV-IN-2
|
Others | Others |
SARS-CoV-IN-2 is an effective SARS-CoV replication inhibitor | |||
T40340 |
SARS-CoV-2-IN-10
|
Others | Others |
SARS-CoV-2-IN-10 is a powerful and non-toxic inhibitor of SARS-CoV-2 3CL protease, with IC50 and EC50 values of 0.13 nM and 1.03 nM, respectively. The SARS-CoV-2 3C-like protease (3CLpro) is a critical enzyme for viral replication and serves as an ideal target for intervention. By targeting the SARS-CoV-2 3CL protease, SARS-CoV-2-IN-10 has the potential to facilitate the development of effective antiviral drugs specific to SARS-CoV-2. | |||
T12836 |
SARS-CoV-2-IN-1
|
Others | Others |
SARS-CoV-2-IN-1 is a potent inhibitor of Mpro(SARS-CoV-2 Mpro, SARS-CoV Mpro and MERS-CoV Mpro with IC50s of 0.67, 0.90 and 0.58 μM, respectively). | |||
T40207 |
SARS-CoV-2-IN-7
|
Others | Others |
SARS-CoV-2-IN-7 demonstrates potent inhibition of viral replication in SARS-CoV-2-infected Vero E6 cells with an IC50 value of 844 nM. | |||
T38942 |
SARS-CoV-2-IN-9
|
Others | Others |
SARS-CoV-2-IN-9 is an inhibitor binding to subsites S1 and S2 in SARS-CoV-2 main protease. | |||
T40341 |
SARS-CoV-2-IN-11
|
Others | Others |
SARS-CoV-2-IN-11 is a highly potent and non-toxic inhibitor of the 3C-like protease (3CLpro) of SARS-CoV-2, demonstrating IC50 and EC50 values of 0.17 nM and 1.45 nM, respectively. This compound targets the essential viral replication enzyme, 3CLpro, making it an attractive candidate for intervention strategies. SARS-CoV-2-IN-11 holds significant promise in the development of specific antivirals against SARS-CoV-2. | |||
T36654 |
Anti-SARS-CoV-2 Spike mAb (CR3022)
Anti-SARS-CoV-2 Spike mAb (CR3022) |
||
Anti-SARS-CoV-2 Spike mAb (CR3022) is a human monoclonal IgG1 antibody derived from CHO cells. It specifically targets the S1 domain of the Spike protein in both SARS-CoV and SARS-CoV-2. | |||
T69535 |
GRL-0820
SARS-CoV-2-IN-6 |
SARS-CoV | Microbiology/Virology |
GRL-0820 (SARS-CoV-2-IN-6) 是一种高效的 SARS-CoV-2 3CLpro 抑制剂,可用于研究新型冠状病毒感染。 | |||
T1817 |
GNF-2
GNF2 |
SARS-CoV; Bcr-Abl | Angiogenesis; Cytoskeletal Signaling; Microbiology/Virology; Tyrosine Kinase/Adaptors |
GNF-2 是一种高选择性的非 ATP 竞争性 Bcr-Abl 抑制剂。 它抑制 Ba/F3.p210 增殖,IC50为 138 nM。 | |||
T12502 |
PLpro inhibitor
5-(乙酰氨基)-2-甲基-N-[(1R)-1-(1-萘基)乙基]苯甲酰胺 |
SARS-CoV | Microbiology/Virology |
PLpro inhibitor 是一种木瓜蛋白酶抑制剂,IC50为 2.6 µM,能抑制 SARS-CoV-2 PLpro。 | |||
T2486 |
IOWH-032
IOWH032,IOWH 032 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
IOWH-032 (IOWH032) 是一种合成 CFTR 抑制剂,可用于研究治疗霍乱、腹泻和分泌性腹泻,在T84和CHO-CFTR 细胞实验中IC50为1.01 uM。 | |||
T9287 |
Hydroxychloroquine
2-[[4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol,羟氯喹 |
SARS-CoV; TLR; Parasite; Autophagy | Autophagy; Immunology/Inflammation; Microbiology/Virology |
Hydroxychloroquine (2-[[4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol) 是一种合成抗疟疾剂,有效抑制SARS-CoV-2感染,也抑制 Toll 样受体 7/9 信号传导。 | |||
T3089 |
6-Thioguanine
6-TG,2-Amino-6-purinethiol,2-Amino-6-mercaptopurine,Thioguanine,6-硫代鸟嘌呤 |
Apoptosis; DNA Methyltransferase; SARS-CoV; Endogenous Metabolite; DUB; Autophagy | Apoptosis; Autophagy; Cell Cycle/Checkpoint; Chromatin/Epigenetic; DNA Damage/DNA Repair; Metabolism; Microbiology/Virology; Ubiquitination |
6-Thioguanine (2-Amino-6-purinethiol) 是一种抗白血病和免疫抑制剂,是 SARS 和 MERS 冠状病毒木瓜样蛋白酶抑制剂,也抑制 USP2的活性,IC50值分别为 25 μM 和 40 μM。 | |||
T60919 |
SARS-CoV-2-IN-13
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-13 (compound 6) 是氯硝柳胺的类似物。在人血浆和肝S9酶测定中,SARS-CoV-2-IN-13 比氯硝柳胺更稳定。SARS-CoV-2-IN-13 口服给药时可以提高生物利用度和半衰期。SARS-CoV-2-IN-13 是SARS-CoV-2的有效抑制剂,IC50值为 0.057 μM。 | |||
T78961 |
SARS-CoV-2-IN-38
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-38是一种 可口服的 SARS-CoV-2抑制剂,具有潜在的抗病毒活性,可用于研究 SARS 病毒感染。 | |||
T63098 |
SARS-CoV-2 Mpro-IN-2
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2 Mpro-IN-2 是一种选择性的SARS-CoV-2M pro抑制剂,IC50 值为 0.40 μM。SARS-CoV-2 Mpro-IN-2 具有良好的抗病毒活性,可用于研究 COVID-19。 | |||
T6833 |
Favipiravir
T-705,6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide,法匹拉韦,法维拉韦 |
Others; SARS-CoV; Influenza Virus; DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Microbiology/Virology; Others |
Favipiravir (T-705) 是一种有效且选择性的 RNA 依赖性 RNA 聚合酶抑制剂,用于治疗流感病毒感染。 | |||
T15781 |
LP-935509
|
Serine/threonin kinase; AAK1 (AP2 associated kinase 1) | Cell Cycle/Checkpoint; Metabolism; Neuroscience |
LP-935509 是一种选择性的、具有脑渗透的、小分子的衔接蛋白-2 相关激酶1 (AAK1) ATP 竞争性抑制剂,其 IC50=3.3 nM,Ki=0.9 nM。它是一种 BIKE 的有效抑制剂 (IC50=14 nM) 和中度的 GAK 抑制剂 (IC50=320 nM)。它能够逆转 SNL 手术后的疼痛。 | |||
T79659 |
SARS-CoV-2 3CLpro-IN-16
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2 3CLpro-IN-16为一种共价 SARS-CoV-2 3CLpro 抑制剂,抑制 3CLpro 活性,通过与Cys145形成共价键实现其抑制作用。 | |||
T62413 |
SARS-CoV-2 nsp13-IN-1
|
Antiviral | Immunology/Inflammation |
SARS-CoV-2 nsp13-IN-1 是一种选择性 nsp13(非结构蛋白 13) 抑制剂,具有抗病毒活性,抑制nsp13 ssDNA+ATPase, 可用于研究COVID-19病毒感染 。 | |||
T1406 |
Amantadine hydrochloride
盐酸金刚烷胺,1-adamantanamine HCl,1-Adamantanamine hydrochloride,Symmetrel,CI-719,Amantadine HCl,1-Adamantylamine hydrochloride |
Dopamine Receptor; Influenza Virus | GPCR/G Protein; Microbiology/Virology; Neuroscience |
Amantadine hydrochloride (CI-719) 是一种抗病毒药物,用于预防或对症治疗甲型流感和帕金森病。它阻断质子流通过 M2 离子通道,从而阻止病毒 RNA 释放到感染细胞的细胞质中。 | |||
T62834 |
SARS-CoV-2-IN-22
|
Others | Others |
SARS-CoV-2-IN-22 是一种 SARS-CoV-2 pseudovirus 抑制剂 (IC50: 16.96 μM)。 | |||
T60785 |
SARS-CoV-2-IN-6
|
Others | Others |
SARS-CoV-2-IN-6 是IC50值为73 nM 的SARS-CoV-2 3CLpro 抑制剂。 | |||
T60962 |
SARS-CoV-2-IN-18
|
Others | Others |
SARS-CoV-2-IN-18 (Compound 26) 是 SARS-CoV-2 3C-样蛋白酶的有效抑制剂 (IC50 = 45 nM)。 | |||
T79243 |
SARS-CoV-2-IN-43
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-43(Compound 8h)是一种有效的抗病毒剂,能够抑制SARS-CoV-2的复制。 | |||
T81207 |
SARS-CoV-2-IN-64
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-64(compound 9)为鹅去氧胆酸衍生物,对SARS-CoV-2刺突糖蛋白具有显著抑制作用。 | |||
T61613 |
SARS-CoV-2-IN-17
|
Others | Others |
SARS-CoV-2-IN-17 (Compound 16) is a highly effective inhibitor of SARS-CoV-2 nucleocapsid protein (NPro). It demonstrates potent anti-viral activity, with an EC50 value of 2.18 μM. Furthermore, SARS-CoV-2-IN-17 binds to NPro with a low Kd value of 7.82 μM, highlighting its potency as a NPro ligand [1]. | |||
T81209 |
SARS-CoV-2-IN-62
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-62 (Compound R3b) 为SARS-CoV-2复制抑制剂,细胞毒性较低。在Vero E6细胞和Calu-3细胞中,其抑制病毒复制的EC50值分别为2.97 μM与3.82 μM。 | |||
T79570 |
SARS-CoV-2-IN-55
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-55 (compound 65) 是一种抑制 SARS-CoV-2 的化合物,具有低细胞毒性,IC50 值为 0.3 μM,它通过作用于病毒的刺突蛋白 S 来抑制病毒感染。 | |||
T74948 |
SARS-CoV-2-IN-30
|
Others | Others |
SARS-CoV-2-IN-30是含有苯环的双臂二磷酸酯分子镊,展现出对SARS-CoV-2的抗病毒效应,其通过抑制SARS-CoV-2活力与病毒尖刺伪粒子转导,具有IC50值分别为0.6μM和6.9μM。此外,SARS-CoV-2-IN-30能导致脂质体膜破坏,其EC50值为6.9μM。 | |||
T79356 |
SARS-CoV-2-IN-57
|
Sigma receptor | GPCR/G Protein |
SARS-CoV-2-IN-57 (化合物(+)-R-26)是一种针对SARS-CoV-2具有高效抑制活性的化合物,其IC50为80 nM。该化合物对Sigma受体表现出高亲和性,与S1R和S2R的Kis值分别为13.6 nM和14.4 nM。 | |||
T63385 |
SARS-CoV-2 3CLpro-IN-2
|
Others | Others |
SARS-CoV-2 3CLpro-IN-2 是 3CL 蛋白酶对有效抑制剂,对SARS-CoV-2疾病表现出研究潜力。 | |||
T62264 |
SARS-CoV-2 nsp13-IN-2
|
Others | Others |
SARS-CoV-2 nsp13-IN-2 (Compound C2) 是一种 SARS-CoV-2 非结构蛋白 13(nsp13)小分子抑制剂,能够作用于 nsp13 ssDNA+ATPase (IC50: 42 μM)。 | |||
T79426 |
SARS-CoV-2-IN-61
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-61(化合物 8i)是SARS-CoV-2 PLpro的抑制剂,其抗病毒活性表现在其IC50值为16 µM。 | |||
T80636 |
SARS-CoV-2-IN-59
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-59(compound E07)为咪唑啉衍生物,其为一种针对SARS-CoV-2的非肽类小分子抑制剂,主要作用于冠状病毒的Mpro。SARS-CoV-2-IN-59于Mpro残基(Met 165, Gln 166,Met165, His 41, Gln 189)处展现出强烈的相互作用。 | |||
T78719 |
SARS-CoV-2-IN-47
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-47(Compound 13)是一种具有针对SARS-CoV-2变体抑制活性的化合物,显示出对Omicron BA.1的IC50值为0.77 μM,以及对Delta病毒株的IC50值为0.93 μM。该化合物可应用于抗病毒研究领域。 | |||
T74946 |
SARS-CoV-2-IN-28
|
Others | Others |
SARS-CoV-2-IN-28 是具备双臂二磷酸 C7 烷基酯和延长分子镊子特征的化合物。该化合物展现出针对SARS-CoV-2的抗病毒效能,能以0.4 μM 的 IC50 抑制 SARS-CoV-2 活性及 1.0 μM 的 IC50 抑制病毒尖刺伪粒子转导。此外,SARS-CoV-2-IN-28 在 EC50 为 4.4 μM 的条件下导致脂质体膜破坏。 | |||
T63292 |
SARS-CoV-2-IN-24
|
Others | Others |
SARS-CoV-2-IN-24 是类木瓜蛋白酶 (PLpro) 的有效抑制剂,能够诱导 SARS-COV-2 木瓜蛋白酶样蛋白酶的构象变化,对 SARS-COV-2 复制具有抑制作用,能够用于研究 SARS-CoV-2。 | |||
T64184 |
SARS-CoV-2-IN-8
|
Others | Others |
SARS-CoV-2-IN-8 是一种 SARS-CoV-2 主要的蛋白酶抑制剂 (IC50: 0.75 μM)。 | |||
T72718 |
SARS-CoV-2-IN-36
|
Others | Others |
SARS-CoV-2-IN-36 是一种针对SARS-CoV-2 Mpro(SARS-CoV)的有效抑制剂, 其酶测定的IC50值为2.37 μM,Kd值为1.19 μM。在Vero细胞试验中, SARS-CoV-2-IN-36 对UC-1074、RG2674 及NVDBB-2220 SARS-CoV-2变体展现了抗病毒活性。 | |||
T79328 |
SARS-CoV-2-IN-54
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-54(Compound 2)为针对SARS-CoV-2的抑制剂,展现出抗病毒活性。它能在Vero E6细胞中抑制SARS-CoV-2,其IC50值为21.4 μM。 | |||
T81203 |
SARS-CoV-2-IN-68
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-68(compound 6C)是共价SARS-CoV-2 PLpro/Mpro抑制剂,展现出有效抗病毒活性,并与PLpro的锌指结构域发生结合。 | |||
T78926 |
SARS-CoV-2-IN-42
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2-IN-42(Compound 8q)是一种有效的SARS-CoV-2复制抑制剂,具有较低的半抑制浓度(EC50: 0.4 μM),且对宿主细胞无明显毒性。 | |||
T63694 |
SARS-CoV-2-IN-33
|
Others | Others |
SARS-CoV-2-IN-33 是 COVID-19 抑制剂。ARS-CoV-2-IN-3 对 COVID-19 主要蛋白酶 (Mpro) (PDB ID:6LU7) 表现出较好的结合亲和力 (-8.0 Kcal/mole)。SARS-CoV-2-IN-33 对癌细胞表现出较好的抗增殖效果。SSARS-CoV-2-IN-33 能够用于研究癌症和 COVID-19。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7991 |
2-Hydroxycinnamic acid
邻羟基肉桂酸(邻香豆酸),(E)-3-(2-羟基苯基)丙烯酸 |
Others; SARS-CoV; HIV Protease | Microbiology/Virology; Others; Proteases/Proteasome |
2-Hydroxycinnamic acid 是从肉桂的甲醇提取物中分离出的一种天然产物,具有光氧化活性。它对HIV/SARS-CoV S 假病毒的感染具有抑制作用,IC50为 0.3 mM。 | |||
T7060 |
Amantadine
1-Aminoadamantane,1-金刚烷胺,金刚烷胺,1-Adamantanamine,1-Adamantylamine |
Others | Others |
Amantadine (1-Aminoadamantane) 是抗病毒药物,也是是 NMDA 型谷氨酸受体的弱拮抗剂,能促进高多巴胺的释放,并阻断多巴胺的再摄取。 | |||
T72581 |
SARS-CoV MPro-IN-2
|
Others | Others |
SARS-CoVMPro-IN-2 是一种有效的SARS-CoV-2 Mpro 抑制剂,IC50sub>值为 72.07 nM。病毒的主要蛋白酶 Mpro 作为加工病毒多蛋白的主要酶,有助于 SARS-CoV-2 在宿主细胞中的复制和转录,并已被定性为药物发现的有吸引力的靶点。SARS-CoVMPro-IN-2 具有研究 COVID-19 的潜力。 | |||
T9715 |
Aplidine
|
SARS-CoV; DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Microbiology/Virology |
Aplidine 是有效的eEF1A2(KD=80 nM) 靶向的抗癌药物。Aplidine 具有抗病毒活性,抑制SARS-CoV-2的 IC90为 0.88 nM。Aplidine 在多发性骨髓瘤,晚期癌症及 COVID-19 领域有研究的价值。 | |||
T8689 |
Chloroquine
CQ,氯喹 |
SARS-CoV; TLR; HIV Protease; Antibiotic; Parasite; Autophagy | Autophagy; Immunology/Inflammation; Microbiology/Virology; Proteases/Proteasome |
Chloroquine 是一种 Toll 样受体抑制剂,可以抑制自噬。Chloroquine 具有抗疟疾和抗炎活性,广泛用于治疗疟疾和类风湿性关节炎。Chloroquine 还具有抗 SARS-CoV-2 (COVID-19) 活性、抗 HIV-1 活性。 | |||
T3S1447 |
Arteannuin B
|
SARS-CoV; Ferroptosis | Apoptosis; Microbiology/Virology |
Arteannuin B 与青蒿素共同存在,有强效抗疟活性,具有抗 SARS-CoV-2 的活性,EC50为 10.28 μM。 | |||
TN3651 |
Cichoriin
|
Others | Others |
Cichoriin 对SARS-CoV-2有明显活性,是治疗重症COVID-19的潜在候选物质。 | |||
T2869 |
Emodin
Frangula emodin,大黄素 |
SARS-CoV; Casein Kinase; Autophagy | Autophagy; Metabolism; Microbiology/Virology; Stem Cells |
Emodin (Frangula emodin) 是蒽醌衍生物,有抗SARS-CoV 作用。它阻断 SARS 冠状病毒刺突蛋白和血管紧张素转化酶 2 的相互作用。它抑制酪蛋白激酶 2 ,具有抗炎和抗癌作用。它可改善饮食诱导的肥胖小鼠的代谢紊乱。 | |||
T2563 |
Acetyl-L-carnitine hydrochloride
Acetyl L-carnitine hydrochloride,O-Acetylcarnitine,乙酰-L-肉(毒)碱盐酸盐,O-acetyl-L-carnitine,O-Acetyl-L-carnitine hydrochloride |
Others; Endogenous Metabolite | Metabolism; Others |
Acetyl-L-carnitine hydrochloride (Acetyl L-carnitine hydrochloride) 是一种由内源性左旋肉碱的乙酰化形式的盐酸盐组成的营养补充剂,具有潜在的神经保护、认知增强、抗抑郁和免疫调节活性。还可缓解化疗、糖尿病或其他疾病引起的周围神经病变。此外,乙酰左旋肉碱可能通过增加T淋巴细胞成熟来调节免疫反应,并可能下调促炎细胞因子对病毒(如SARS-CoV-2)的反应。它还可能破坏ACE2信号通路并抑制活性氧(ROS)的产生。 | |||
TQ0180 |
Chebulagic acid
|
SARS-CoV; Influenza Virus; Lipoxygenase; COX | Immunology/Inflammation; Metabolism; Microbiology/Virology; Neuroscience |
Chebulagic acid 是从 Terminalia chebula Retz 中分离出来的一种 COX-LOX 双重抑制剂,有抗炎和抗感染作用。它抑制 SARS-CoV-2病毒的复制,EC50值为 9.76 μM。它还是 M2(S31N)抑制剂和抗流感病毒剂。 | |||
T0194 |
Chloroquine phosphate
Chloroquine diphosphate,Aralen phosphate,磷酸氯喹,Chingamin phosphate |
SARS-CoV; TLR; HIV Protease; Antibiotic; Parasite; Autophagy | Autophagy; Immunology/Inflammation; Microbiology/Virology; Proteases/Proteasome |
Chloroquine phosphate (Aralen phosphate) 是广泛用于疟疾和类风湿性关节炎的抗疟疾和抗炎剂。它是autophagy 和toll-like receptors 抑制剂,有效抑制SARS-CoV-2(COVID-19) 感染 (EC50=1.13 μM)。 | |||
T21883 |
Gedunin
|
HSP | Cytoskeletal Signaling; Metabolism |
Gedunin 是从印楝种子中提取的一种重要柠檬苦素,具有抗癌、抗病毒、抗炎和杀虫活性。它可阻断 SARS-CoV-2 病毒进入人宿主细胞,用于 COVID-19 研究。它是Hsp90抑制剂,诱导 Hsp90 依赖的蛋白降解,抑制卵巢癌细胞增殖。 | |||
T6670 |
Silymarin
Silybin B,水飞蓟素 |
SARS-CoV | Microbiology/Virology |
Silymarin (Silybin B) 是一种多酚类黄酮,是从水飞蓟或水飞蓟的种子中提取的一种 SARS-CoV-2 主蛋白酶抑制剂。它可降低肿瘤细胞的增殖,血管生成以及胰岛素抵抗,用于预防和治疗肝脏疾病,有潜力研究 COVID-19 。 | |||
TN2302 |
Viscidulin III
Ganhuangenin |
Glucosidase | Metabolism |
Viscidulin III (Ganhuangenin) 存在于黄芩中,可作为α-葡萄糖苷酶抑制剂。 | |||
T79947 |
10-Hydroxyaloin A
|
SARS-CoV | Microbiology/Virology |
10-Hydroxyaloin A有效抑制SARS-CoV-2,与SARS-CoV-2 Mpro活性位点显著结合。 | |||
T73561 |
NK007
|
Others | Others |
NK007 是一种新型抗 SARS-CoV-2 药物,其 EC50值为 30 nM。 | |||
T80010 |
(25S)-Antcin B
|
SARS-CoV | Microbiology/Virology |
Antcin-B是3CLPro的高亲和力有效抑制剂,可用于SARS-CoV-2的研究。 | |||
T73900 |
(±)-Alliin
|
Others | Others |
(±)-Alliin 是大蒜的主要活性成分。(±)-Alliin 被认为是SARS-CoV-2 (Mpro)的虚拟抑制剂。 | |||
T75533 |
Dihydromaniwamycin E
|
Others | Others |
Dihydromaniwamycin E 是一种热休克代谢物,对influenza 和SARS-CoV-2病毒具有抗病毒活性。 | |||
T75534 |
Maniwamycin E
|
Others | Others |
Maniwamycin E,一种耐热链霉菌培养提取物中分离得到的马尼瓦霉素衍生物,展示了对SARS-CoV-2和H1N1流感病毒的抗病毒活性。 | |||
T75540 |
Ipomoeassin F
|
Others | Others |
Ipomoeassin F 是一种高效且具有选择性的内质网(ER)蛋白转位抑制剂,它通过作用于ER膜上的Sec61复合物(Sec61α)的成孔亚基来实现其功能。此化合物能特异性抑制SARS-CoV-2蛋白在ER膜上的转位,同时阻碍分泌蛋白和I型跨膜蛋白(TMP)的ER转运,但对III型TMP的转运不产生影响。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPJ-01426 |
SARS-CoV-2 NSP2 Protein (His)
SARS-CoV 2 nsp2,SARS... |
SARS-CoV-2 | E. coli |
The positive-stranded RNA genome of the coronaviruses is translated from ORF1 to yield polyproteins that are proteolytically processed into intermediate and mature nonstructural proteins (nsps). SARS-CoV 2 polyproteins incorporate 16 protein domains (nsps). The putative non-structural protein 2 (nsp2) of SARS-CoV plays an important role in viral transcription and replication, and is an attractive target for anti-SARS drug development. | |||
TMPJ-01450 |
SARS-CoV-2 Helicase Protein (His & MBP)
SARS-CoV 2 nsp13,SARS- |
SARS-CoV-2 | E. coli |
The non—structural protein 13 (nsp13) of SARS—CoV 2 is a helicase that separates double—stranded RNA or DNA with a 5'—3' polarity, using the energy of nucleotide hydrolysis. A basic biochemical characterization of nsp13 demonstrated that it can unwind both doublestranded DNA and RNA in a 5’-3’ direction, and it can hydrolyze all deoxyribonucleotide and ribonucleotide triphosphates. Helicases are motor proteins that utilize the energy derived from nucleotide hydrolysisto unwind double-stranded nu... | |||
TMPJ-01425 |
SARS-CoV-2 NSP1 Protein (His)
SARS-CoV 2 nsp1,SARS- |
SARS-CoV-2 | E. coli |
The Severe Acute Respiratory Syndrome (SARS) Coronavirus (CoV) is an enveloped, positive-stranded RNA viruses that can cause a severe respiratory disease. Its genome consists of a ∼30 kb linear, non-segmented, capped, polycistronic, polyadenylated RNA molecule, the first two-third of which is directly translated into two large polyproteins. These two polypeptides are processed into 16 non-structural proteins (nsps), forming the replicase complex, which is active in the cytoplasm in close associa... | |||
TMPJ-01428 |
SARS-CoV-2 NSP8 Protein (His)
SARS-CoV 2 nsp8 |
SARS-CoV-2 | E. coli |
Cleavage by the viral main protease, 3CLpro results in generating the nsp8 protein, The nsp8 protein has been shown to associate with several other nsps and to colocalize with these nsps in cytoplasmic complexes that are important for viral RNA synthesis. It forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, may synthesize substantially longer products than oligonucleotide primers.Nsp8 was shown to have RNA-dependen... | |||
TMPJ-01427 |
SARS-CoV-2 NSP7 Protein (His)
SARS-CoV 2 nsp7 |
SARS-CoV-2 | E. coli |
The ∼30kb positive-stranded RNA genome of coronaviruses encodes a replication/transcription machinery that is unusually complex and composed of 16 nonstructural proteins (nsps). The four proteins nsp7 to nsp10, which are conserved among all CoVs but have no functional homologs outside of the Coronaviridae, are translated as part of the viral polyproteins pp1a and pp1ab, and the mature proteins are released by the action of the SARS-CoV protease nsp5. Hexadecamer of nsp7 and nsp8 may possess dsRN... | |||
TMPJ-01429 |
SARS-CoV-2 Guanine-N7 methyltransferase Protein (His)
SARS-CoV 2 nsp14,Guanine-N7 methy... |
SARS-CoV-2 | E. coli |
The nonstructural protein (nsp) 14 of SARS-CoV 2 was identified as a cap (guanine-N7)-methyltransferase (N7-MTase). Nsp14 of coronaviruses two different activities: an exoribonuclease activity acting on both ssRNA and dsRNA in a 3' to 5' direction and a N7-guanine methyltransferase activity. It may be involved in the proof-reading ability during the viral RNA replication and transcription. GTP, dGTP as well as cap analogs GpppG, GpppA and m7GpppG could be methylated by nsp14. | |||
TMPK-01412 |
HLA-B*15:01&B2M&SARS-CoV-2 epitope (NQKLIANQF) Monomer Protein, Human, MHC (His & Avi)
SARS-CoV-2 epitope,MHC |
Human | HEK293 Cells |
HLA-B*15:01 is strongly associated with asymptomatic infection with SARS-CoV-2 and is likely to be involved in the mechanism underlying early viral clearance. T cells from pre-pandemic individuals carrying HLA-B*15:01 were reactive to the immunodominant SARS-CoV-2 S-derived peptide NQKLIANQF, and 100% of the reactive cells displayed memory phenotype. | |||
TMPK-01416 |
HLA-B*15:01&B2M&SARS-CoV-2 epitope (NQKLIANQF) Monomer Protein, Human, MHC (His & Avi), Biotinylated
MHC,SARS-CoV-2 epitope |
Human | HEK293 Cells |
HLA-B*15:01 is strongly associated with asymptomatic infection with SARS-CoV-2 and is likely to be involved in the mechanism underlying early viral clearance. T cells from pre-pandemic individuals carrying HLA-B*15:01 were reactive to the immunodominant SARS-CoV-2 S-derived peptide NQKLIANQF, and 100% of the reactive cells displayed memory phenotype. | |||
TMPY-05679 |
SARS-CoV-2 Spike RBD Protein (hFc)
|
SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (hFc) is expressed in HEK293 mammalian cells. The predicted molecular weight is 51.8 kDa and the accession number is A0A6G7K2L4. | |||
TMPK-00265 |
SARS-COV-2 Nucleocapsid Protein (His & Avi), Biotinylated
Nucleocapsid,NC,NP |
SARS-CoV-2 | E. coli |
Nucleocapsid protein (N) is the major viral structural component; its main function is to protect and encapsidate the viral RNA forming viral RNP complex. It is encoded by the S segment vRNA and is abundantly expressed in the cytoplasm of infected cells. SARS-COV-2 Nucleocapsid Protein (His & Avi), Biotinylated is expressed in E. coli expression system with N-His-Avi tag. The predicted molecular weight is 48.9 kDa and the accession number is P0DTC9. | |||
TMPY-06078 |
SARS-CoV-2 envelope(CoV-E) protein Protein (C40A & C43A & C44A, His & MBP)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 envelope(CoV-E) protein Protein (C40A & C43A & C44A, His & MBP) is expressed in E. coli expression system. The predicted molecular weight is 52.2 kDa and the accession number is YP_009724392.1. | |||
TMPY-06071 |
SARS-CoV-2 RNA-dependent RNA polymerase/RDRP Protein (His)
|
SARS-CoV-2 | Baculovirus Insect Cells |
SARS-CoV-2 RNA-dependent RNA polymerase/RDRP Protein (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 108.3 kDa and the accession number is YP_009725307.1. | |||
TMPY-06615 |
SARS-CoV-2 XBB (Omicron) Spike S1+S2 trimer Protein (His)
|
SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 XBB (Omicron) Spike S1+S2 trimer Protein (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 136.26 kDa and the accession number is YP_009724390.1. | |||
TMPY-06626 |
SARS-COV-2 BQ.1/BQ.1.1 (Omicron) Nucleoprotein/NP Protein (His)
|
SARS-CoV-2 | E. coli |
SARS-COV-2 BQ.1/BQ.1.1 (Omicron) Nucleoprotein/NP Protein (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 46.36 kDa and the accession number is YP_009724397.2. | |||
TMPY-06416 |
SARS-CoV-2 NSP8 Protein
|
SARS-CoV-2 | E. coli |
NSP8 is a nonstructural protein of coronavirus. NSP8 acts as a primase in RNA synthesis. NSP8 and NSP7 are essential co-factors of NSP12 (the catalytic subunit with RNA-dependent RNA polymerase activity) that can remarkably stimulate RdRp activity. The nsp12-nsp7-nsp8 subcomplex is defined as the minimal core component for mediating coronavirus RNA synthesis. SARS-CoV-2 NSP8 Protein is expressed in E. coli expression system. The predicted molecular weight is 22.04 kDa and the accession number is... | |||
TMPY-06009 |
SARS-CoV-2 NSP7 Protein
|
SARS-CoV-2 | E. coli |
NSP7 is conserved within the coronaviridae. NSP7 is a component of the coronavirus replicase polyprotein to comprise a repilication complex. NSP7 has been shown to interact with NSP10 and NSP1 which indicate that NSP7 has a founction in coronavirus-specific RNA replication mechanisms. | |||
TMPY-06012 |
SARS-CoV-2 NSP10 Protein
|
SARS-CoV-2 | E. coli |
NSP10 is a major regulator of coronavirus replicase function. NSP10 contains two zinc fingers and binds and stimulates both NSP14 and NSP16 activities. Researchers has found that the nsp10 surface that interacts with nsp14 and nsp16 and possibly other subunits of the viral replication complex may be a target for the development of antiviral compounds against pathogenic coronaviruses. SARS-CoV-2 NSP10 Protein is expressed in E. coli expression system. The predicted molecular weight is 15 kDa and ... | |||
TMPY-05820 |
SARS-CoV-2 NSP3 Protein (His)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 NSP3 Protein (His) is expressed in E. coli expression system. The predicted molecular weight is 19.87 kDa and the accession number is YP_009725299.1. | |||
TMPY-05664 |
SARS-CoV-2 Nucleocapsid Protein (His)
|
SARS-CoV-2 | Baculovirus Insect Cells |
SARS-CoV-2 Nucleocapsid Protein (His) is expressed in Baculovirus insect cells. The predicted molecular weight is 47.08 kDa and the accession number is P0DTC9. | |||
TMPY-06086 |
SARS-CoV-2 Helicase Protein (His)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 Helicase Protein (His) is expressed in E. coli expression system. The predicted molecular weight is 67.8 kDa and the accession number is YP_009725308.1. | |||
TMPY-06011 |
SARS-CoV-2 NSP10 Protein (His)
|
SARS-CoV-2 | E. coli |
NSP10 is a major regulator of coronavirus replicase function. NSP10 contains two zinc fingers and binds and stimulates both NSP14 and NSP16 activities. Researchers has found that the nsp10 surface that interacts with nsp14 and nsp16 and possibly other subunits of the viral replication complex may be a target for the development of antiviral compounds against pathogenic coronaviruses. SARS-CoV-2 NSP10 Protein (His) is expressed in E. coli expression system. The predicted molecular weight is 15.7 ... | |||
TMPY-05749 |
SARS-CoV-2 NSP8 Protein (Avi)
|
SARS-CoV-2 | E. coli |
NSP8 is a nonstructural protein of coronavirus. NSP8 acts as a primase in RNA synthesis. NSP8 and NSP7 are essential co-factors of NSP12 (the catalytic subunit with RNA-dependent RNA polymerase activity) that can remarkably stimulate RdRp activity. The nsp12-nsp7-nsp8 subcomplex is defined as the minimal core component for mediating coronavirus RNA synthesis. SARS-CoV-2 NSP8 Protein (Avi) is expressed in E. coli expression system. The predicted molecular weight is 24.17 kDa and the accession num... | |||
TMPY-05695 |
SARS-CoV-2 Nucleocapsid Protein (His), Biotinylated
|
SARS-CoV-2 | Baculovirus Insect Cells |
SARS-CoV-2 Nucleocapsid Protein (His), Biotinylated is expressed in Baculovirus insect cells. The predicted molecular weight is 47.08 kDa and the accession number is P0DTC9. | |||
TMPY-05712 |
SARS-CoV-2 NSP9 Protein (His & Avi)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 NSP9 Protein (His & Avi) is expressed in E. coli expression system. The predicted molecular weight is 15.46 kDa and the accession number is YP_009725305.1. | |||
TMPY-06144 |
SARS-CoV-2 Nucleocapsid Protein (D377Y, His)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 Nucleocapsid Protein (D377Y, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 46.5 kDa and the accession number is P0DTC9. | |||
TMPY-06190 |
SARS-CoV-2 Nucleocapsid Protein (P199L, His)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 Nucleocapsid Protein (P199L, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 46.6 kDa and the accession number is P0DTC9. | |||
TMPY-06113 |
SARS-CoV-2 Nucleocapsid CTD Protein (His)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 Nucleocapsid CTD Protein (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 14.2 kDa and the accession number is P0DTC9. | |||
TMPY-05681 |
SARS-CoV-2 Spike RBD Protein (rFc)
|
SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (rFc) is expressed in HEK293 mammalian cells. The predicted molecular weight is 50.3 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06098 |
SARS-CoV-2 Nucleocapsid Protein (I292T, His)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 Nucleocapsid Protein (I292T, His) is expressed in E. coli expression system. The predicted molecular weight is 46.6 kDa and the accession number is P0DTC9. | |||
TMPY-06123 |
SARS-CoV-2 Nucleocapsid Protein (P80R, His)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 Nucleocapsid Protein (P80R, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 46.7 kDa and the accession number is P0DTC9. | |||
TMPY-06124 |
SARS-CoV-2 Nucleocapsid Protein (T205I, His)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 Nucleocapsid Protein (T205I, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 46.6 kDa and the accession number is P0DTC9. | |||
TMPY-06097 |
SARS-CoV-2 Nucleocapsid Protein (S194L, His)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 Nucleocapsid Protein (S194L, His) is expressed in E. coli expression system. The predicted molecular weight is 46.6 kDa and the accession number is P0DTC9. | |||
TMPY-05663 |
SARS-CoV-2 Spike RBD Protein (mFc)
|
SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (mFc) is expressed in HEK293 mammalian cells. The predicted molecular weight is 51.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05667 |
SARS-CoV-2 Spike S1 Protein (His)
|
SARS-CoV-2 | Baculovirus Insect Cells |
SARS-CoV-2 Spike S1 Protein (His) is expressed in Baculovirus insect cells. The predicted molecular weight is 76.45 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06189 |
SARS-CoV-2 Nucleocapsid Protein (A220V, His)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 Nucleocapsid Protein (A220V, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 46.6 kDa and the accession number is P0DTC9. | |||
TMPJ-01431 |
SARS-CoV-2 Papain-Like Protease Protein
PLpro,PL-PRO,pp1a,Replicase polyprotein 1a,Papain-like Prote... |
SARS-CoV-2 | E. coli |
Replication of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) requires proteolytic processing of the replicase polyprotein by two viral cysteine proteases, a chymotrypsin-like protease (3CLpro) and a papain-like protease (PLpro). These proteases are important targets for development of antiviral drugs that would inhibit viral replication and reduce mortality associated with outbreaks of SARS-CoV. PLpro is a cysteine protease located within the non-structural protein 3 (NS3) sect... | |||
TMPY-05660 |
SARS-CoV-2 Spike S1 Protein (hFc)
|
SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike S1 Protein (hFc) is expressed in HEK293 mammalian cells. The predicted molecular weight is 101.7 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05668 |
SARS-CoV-2 Spike RBD Protein (His)
|
SARS-CoV-2 | Baculovirus Insect Cells |
SARS-CoV-2 Spike RBD Protein (His) is expressed in Baculovirus insect cells. The predicted molecular weight is 26.54 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06188 |
SARS-CoV-2 Nucleocapsid Protein (M234L, His)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 Nucleocapsid Protein (M234L, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 46.6 kDa and the accession number is P0DTC9. | |||
TMPY-06221 |
SARS-CoV-2 Nucleocapsid Protein (P67S, His)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 Nucleocapsid Protein (P67S, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 46.6 kDa and the accession number is P0DTC9. | |||
TMPY-06217 |
SARS-CoV-2 Nucleocapsid Protein (S202N, His)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 Nucleocapsid Protein (S202N, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 46.6 kDa and the accession number is P0DTC9. | |||
TMPY-06114 |
SARS-CoV-2 Nucleocapsid NTD Protein (His)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 Nucleocapsid NTD Protein (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 14.9 kDa and the accession number is P0DTC9. | |||
TMPY-06145 |
SARS-CoV-2 Nucleocapsid Protein (E378Q, His)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 Nucleocapsid Protein (E378Q, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 46.5 kDa and the accession number is P0DTC9. | |||
TMPK-00263 |
SARS-COV-2 Nucleocapsid Protein (His & Avi)
NC,Nucleocapsid,NP |
SARS-CoV-2 | E. coli |
Nucleocapsid protein (N) is the major viral structural component; its main function is to protect and encapsidate the viral RNA forming viral RNP complex. It is encoded by the S segment vRNA and is abundantly expressed in the cytoplasm of infected cells. SARS-COV-2 Nucleocapsid Protein (His & Avi) is expressed in E. coli expression system with N-His-Avi tag. The predicted molecular weight is 48.9 kDa and the accession number is P0DTC9. | |||
TMPY-05693 |
SARS-CoV-2 Methyltransferase/ME Protein (His)
|
SARS-CoV-2 | E. coli |
Coronavirus encodes the 2’-O-MTase (2'O Methyltransferase) that is composed of the catalytic subunit nsp16 and the stimulatory subunit nsp10 and plays an important role in virus genome replication and evasion from innate immunity during viral infection. Nonstructural protein 16 (NSP16) / viral 2'O-methyltransferase (2'O-MTase) is highly conserved. The conserved 2'O-MTase activity is important for CoV pathogenesis and NSP16 is a conserved universal target for rapid live attenuated vaccine design ... | |||
TMPY-05662 |
SARS-CoV-2 Spike S1 Protein (mFc)
|
SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike S1 Protein (mFc) is expressed in HEK293 mammalian cells. The predicted molecular weight is 101.4 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06096 |
SARS-CoV-2 Nucleocapsid Protein (P13L, His)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 Nucleocapsid Protein (P13L, His) is expressed in E. coli expression system. The predicted molecular weight is 46.6 kDa and the accession number is P0DTC9. | |||
TMPY-05975 |
SARS-CoV-2 Spike RBD Protein (P521S, His)
|
SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (P521S, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06041 |
SARS-CoV-2 Spike RBD Protein (K458Q, His)
|
SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (K458Q, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05990 |
SARS-CoV-2 Spike RBD Protein (S477I, His)
|
SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (S477I, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
------------------------ 更多 ------------------------ |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T60016 |
VV116
GS-621763-d1,JT001 |
SARS-CoV; RSV | Microbiology/Virology |
VV116 (JT001) 是一种针对呼吸道合胞病毒和 SARS-CoV-2 感染的选择性和口服活性核苷抗病毒剂。 | |||
TMIH-0394 |
Nirmatrelvir-d9
|
||
Nirmatrelvir-d9 是 Nirmatrelvir 的氘代化合物。Nirmatrelvir 的 CAS 号为 2628280-40-8。PF-07321332 是一种有效的口服活性SARS-CoV 3CLPRO抑制剂,对 SARS-CoV-2 病毒有针对性,可研究 COVID-19。它是一种胰蛋白酶样蛋白酶抑制剂,可抑制气道上皮钠通道功能。 | |||
TMIH-0146 |
Chloroquine-d5
|
||
Chloroquine-d5 是 Chloroquine 的氘代化合物。Chloroquine 的 CAS 号为 54-05-7。Chloroquine 是一种自噬和 Toll 样受体抑制剂。 氯喹是一种抗疟疾和抗炎剂,广泛用于治疗疟疾和类风湿性关节炎。它在体外控制 SARS-CoV-2 (COVID-19) 感染方面非常有效,EC50 为 1.13 μM。 | |||
T38297 |
Ribavirin-13C5
Ribavirin-13C5 |
||
Ribavirin-13C5is intended for use as an internal standard for the quantification of ribavirin by GC- or LC-MS. Ribavirin is an antiviral guanosine nucleoside analog.1,2Upon entry into cells, ribavirin is metabolized to an active triphosphate form that induces viral RNA chain termination and inhibits viral polymerases. It reduces replication in a panel of seven RNA and four DNA viruses in Vero cells (EC50s = 2-95 μg/ml).3Ribavirin also reduces replication of severe acute respiratory syndrome coro... | |||
TMIJ-0076 |
Ritonavir-13C-d3
|
||
Ritonavir-13C-d3 是 Ritonavir 的 13C 和氘代化合物。Ritonavir 的 CAS 号为 155213-67-5。Ritonavir 是一种 HIV 蛋白酶抑制剂,可研究 HIV 感染和 AIDS 。它也是SARS-CoV 3CLpro的抑制剂,IC50为 1.61 μM。 | |||
TMIJ-0339 |
Bromhexine-d3 HCl
|
||
Bromhexine-d3 HCl 是 Bromhexine HCl 的氘代化合物。Bromhexine HCl 的 CAS 号为 611-75-6。Bromhexine hydrochloride 是TMPRSS2蛋白酶的一种特异性有效抑制剂,IC50为 0.75 μM。它可预防和控制SARS-CoV-2感染。它是一种粘液溶解剂,用于治疗与粘稠或过多粘液相关的呼吸系统疾病。 | |||
TMID-0208 |
Hydroxychloroquine-d5
|
||
Hydroxychloroquine-d5 是 Hydroxychloroquine 的氘代化合物。Hydroxychloroquine 的 CAS 号为 118-42-3。Hydroxychloroquine 是一种合成抗疟疾剂,有效抑制SARS-CoV-2感染,也抑制 Toll 样受体 7/9 信号传导。 | |||
TMID-0083 |
Arbidol-d6 Hydrochloride
|
||
Arbidol-d6 Hydrochloride 是 Arbidol Hydrochloride 的氘代化合物。Arbidol Hydrochloride 的 CAS 号为 131707-23-8。Umifenovir hydrochloride 是一种口服有效的广谱抗病毒药物,对多种包膜和非包膜病毒均有活性。它被用作抗流感病毒剂,可通过阻断病毒与宿主细胞膜的融合来抑制包膜病毒的细胞侵袭。它是一种 SARS-CoV-2 抑制剂,具有抗炎活性。 |